UK begins mass COVID-19 vaccination with Pfizer-BioNTech vaccine
The UK's National Health Service launched a mass vaccination campaign using the BNT162b2 vaccine developed by BioNTech and Pfizer. The first doses were administered to seniors over 80 and selected healthcare workers.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthUK begins mass COVID-19 vaccination with Pfizer-BioNTech vaccine
Sign in or subscribeBrowse free archive reportsThe UK's National Health Service launched a mass vaccination campaign using the BNT162b2 vaccine developed by BioNTech and Pfizer. The first doses were administered to seniors over 80 and selected healthcare workers.